GRI NASDAQ
GRI Bio, Inc.
1W: -4.4%
1M: -2.0%
3M: +8.3%
YTD: -75.0%
1Y: -96.5%
3Y: -100.0%
5Y: -100.0%
$1.96
+0.00 (+0.00%)
Weekly Expected Move ±22.4%
$1
$2
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2022-12-13
Earliest Filing
2026-01-30
Latest Filing
partner: 1
acquirer: 1
supplier: 1
target: 1
investor: 1
Counterparties (Filed by GRI)
5 relationshipsCompanies named in GRI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for the Company's At The Market Offering Agreement | 2026-01-30 | View |
| Aardvark Therapeutics, Inc. | AARD | acquirer | Agreed to purchase GRI Bio's license agreement, certain patents, and files for the ADAIR product candidate. | 2023-08-23 | View |
| Medice Arzneimittel Pűtter GmbH & Co. KG | — | supplier | Original licensor whose agreement with GRI Bio was purchased by Aardvark Therapeutics. | 2023-08-23 | View |
| GRI Bio, Inc. | GRI | target | Target company in the merger agreement with Vallon Pharmaceuticals, Inc. | 2022-12-13 | View |
| Altium Growth Fund, LP | — | investor | Investor in the pre-merger bridge financing and equity financing agreements. | 2022-12-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-08 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-18 | Other Events; Exhibits | View | |
| 2026-05-14 | Earnings Release; Other Events; Exhibits | View | |
| 2026-02-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-30 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-01-28 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-21 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-01-16 | Notice of Delisting or Transfer | View | |
| 2026-01-15 | Submission of Matters to a Vote of Security Holders; Other Events | View | |
| 2026-01-09 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-12 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-10 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-08 | Other Events | View | |
| 2025-12-02 | Notice of Delisting or Transfer | View | |
| 2025-08-20 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-13 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-07-31 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-26 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR